Related Experiment Video
Updated: Nov 1, 2025

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
Published on: December 24, 2015
Aging and Mesenchymal Stem Cells: Therapeutic Opportunities and Challenges in the Older Group
Huan Chen1, Ousheng Liu1, Sijia Chen1
1Hunan Key Laboratory of Oral Health Research, Hunan 3D Printing Engineering Research Center of Oral Care, Hunan Clinical Research Center of Oral Major Diseases and Oral Health, Xiangya Stomatological Hospital, and Xiangya School of Stomatology, Central South University, Changsha, China.
Abstract:
With aging, a portion of cells, including mesenchymal stem cells (MSCs), become senescent, and these senescent cells accumulate and promote various age-related diseases. Therefore, the older age group has become a major population for MSC therapy, which is aimed at improving tissue regeneration and function of the aged body. However, the application of MSC therapy is often unsatisfying in the aged group. One reasonable conjecture for this correlation is that aging microenvironment reduces the number and function of MSCs. Cellular senescence also plays an important role in MSC function impairment. Thus, it is necessary to explore the relationship between senescence and MSCs for improving the application of MSCs in the elderly. Here, we present the influence of aging on MSCs and the characteristics and functional changes of senescent MSCs. Furthermore, current therapeutic strategies for improving MSC therapy in the elderly group are also discussed.
Insights
Cellular senescence impairs mesenchymal stem cells (MSCs) in older adults, reducing MSC therapy effectiveness. Understanding senescence in MSCs is key to improving regenerative treatments for the elderly.
Area of Science:
- Gerontology and Regenerative Medicine
- Cellular Biology and Aging
Background:
- Cellular senescence, a state of irreversible growth arrest, increases with age and contributes to age-related diseases.
- Mesenchymal stem cells (MSCs) are crucial for tissue regeneration, but their efficacy declines in older individuals.
- The aging microenvironment and cellular senescence negatively impact MSC number and function.
Purpose of the Study:
- To investigate the effects of aging on MSCs.
- To characterize the changes in senescent MSCs.
- To discuss strategies for enhancing MSC therapy in the elderly population.
Main Methods:
- Review of existing literature on cellular senescence and MSCs in aging.
- Analysis of the functional and characteristic alterations in senescent MSCs.
- Discussion of current and potential therapeutic interventions.
Main Results:
- Aging leads to an accumulation of senescent cells, including MSCs.
- Senescent MSCs exhibit impaired regenerative capacity and altered functionality.
- The aging microenvironment exacerbates MSC dysfunction.
Conclusions:
- Cellular senescence is a significant factor limiting the success of MSC therapy in the elderly.
- Targeting senescence in MSCs or the microenvironment may improve therapeutic outcomes.
- Further research is needed to optimize MSC applications for age-related conditions.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
The Effect of Aging on Tissues
Stem Cell Culture
Adult Stem Cells

